Position in HALO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,756,099
-$1,012,884 QoQ
Shares Held
47,989
-35.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#175
of 666 holders
Holding Since
Jun 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OMERS ADMINISTRATION Corp holds $69,579,172 across 33 Biotechnology names. HALO ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
50,671 | $12,402,740 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,073 | $10,467,591 | |
| 3 | RPRX |
Royalty Pharma plc
|
133,435 | $7,481,700 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,099 | $6,297,130 | |
| 5 | INCY |
Incyte Corp
|
45,186 | $5,122,284 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
47,989 | $3,756,099 | |
| 7 | CORT |
Corcept Therapeutics Inc
|
30,700 | $2,669,365 | |
| 8 | RIGL |
Rigel Pharmaceuticals Inc
|
51,900 | $2,030,328 |
All Filings in HALO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,756,099 | 47,989 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $4,768,983 | 73,789 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,370,989 | 50,089 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,085,432 | 14,800 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $769,896 | 14,800 | Shares | Sole | 2025-08-13 | |
| 2024-06-30 | $324,632 | 6,200 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||